Research Topics
| Francesco AzzaroliSummaryAffiliation: University of Bologna Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acidF Azzaroli
Dipartimento di Medicina Interna e Gastroenterologia, Universita degli Studi di Bologna, Bologna, Italy
Aliment Pharmacol Ther 26:1139-46. 2007..The effects of ursodeoxycholic acid on human placental bile acids and bilirubin transporters in intrahepatic cholestasis of pregnancy are still undefined...
Pneumatosis cystoides intestinalisFrancesco Azzaroli
Department of Clinical Medicine, Division of Gastroenterology, S Orsola Malpighi Hospital, University of Bologna, 40138 Bologna, Italy
World J Gastroenterol 17:4932-6. 2011....- The pharmacological management of intrahepatic cholestasis of pregnancyFrancesco Azzaroli
Department of Clinical Medicine, Gastroenterology Unit, St Orsola Malpighi Hospitali, University of Bologna, Italy
Curr Clin Pharmacol 6:12-7. 2011..The present manuscript will review the current knowledge on the pharmacological treatment of intrahepatic cholestasis of pregnancy... - G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrenceFrancesca Lodato
Department of Digestive Diseases and Internal Medicine, University of Bologna, Bologna 40138, Italy
World J Gastroenterol 15:5449-54. 2009.... - Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trialM Francesca Jaboli
Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
World J Gastroenterol 9:1491-5. 2003..Studies with other regimens regarding sequence and duration are needed... 
High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-onMarco Montagnani
Department of Clinical Medicine, Gastroenterology Unit, St Orsola Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy
Dig Dis Sci 57:561-7. 2012....- Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosisFrancesco Azzaroli
Department of Internal Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna
World J Gastroenterol 10:3099-102. 2004..Data on the preventive effect of IFN plus ribavirin treatment are lacking... - Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseasesDavide Festi
Department of Internal Medicine and Gastroenterology, Policlinico S Orsola Malpighi, Bologna, Italy
Curr Clin Pharmacol 2:155-77. 2007..The future availability of UDCA derivatives will possibly enhance the chances to effectively treat chronic cholestatic diseases... - Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nationsFrancesca Lodato
Dipartimento di Medicina Interna e Gastroenterologia, UO di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
World J Gastroenterol 12:7239-49. 2006..Thus the real contribution of medical treatment to HCC prevention in patients with chronic viral hepatitis is small. Great efforts are needed to identify more effective medical measures for primary and secondary prevention of HCC... - Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrenceFrancesca Lodato
Dipartimento di Medicina Interna e Gastroenterologia, U O di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
World J Gastroenterol 12:4253-5. 2006.... - Proton pump inhibitors in cirrhosis: tradition or evidence based practice?Francesca Lodato
Dipartimento di Medicina Interna e Gastroenterologia, U O di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
World J Gastroenterol 14:2980-5. 2008..In conclusion, the use of this class of drugs seems more habit related than evidence-based eventually leading to an increase in health costs... - A new model for portal protein profile analysis in course of ileal intraluminal bile acid infusion using an in situ perfused rat intestineMarco Montagnani
Dipartimento di Medicina Clinica, Centro di Ricerca Biomedica Applicata Policlinico S Orsola, Universita di Bologna, Bologna, Italy
Med Chem 7:257-64. 2011..Since FGF15 was not recovered we suggest the possibilities that this protein is produced in very little amounts, poorly transferred outside the cell, or that it is extremely unstable and rapidly degraded... - Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agentFrancesca Lodato
Department of Internal Medicine and Gastroenterology, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
Liver Transpl 12:1711-4. 2006..They may cause both localized and disseminated infection. In conclusion, Fusarium spp. etiology should be considered in the context of infectious diseases following liver transplantation... - Adverse effects of proton pump inhibitorsFrancesca Lodato
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
Best Pract Res Clin Gastroenterol 24:193-201. 2010..In fact, in clinical practise, PPI are often prescribed in patients without a specific acid related disease and continued long term based on their safety profile. This review focus on the main adverse events related to long term PPI use... - Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapyCarlo Fabbri
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
World J Gastroenterol 9:1487-90. 2003.... - Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experienceFrancesca Lodato
Department of Digestive Diseases and Internal Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
Scand J Gastroenterol 47:1494-500. 2012..Different models have been proposed for the prediction of survival after TIPS. The aim of this study was to evaluate the predictive factors associated with patients' survival after TIPS placement for refractory ascites... - Natural history of small gallbladder polyps is benign: evidence from a clinical and pathogenetic studyAntonio Colecchia
Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
Am J Gastroenterol 104:624-9. 2009..It is unclear if these polyps and gallstones represent different aspects of the same disease. The aim of this study was to characterize the natural history and pathogenesis of small gallbladder polyps... - ESWL for difficult bile duct stones: a 15-year single centre experienceRosangela Muratori
Department of Digestive Diseases and Internal Medicine, S Orsola Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy
World J Gastroenterol 16:4159-63. 2010..To evaluate the efficacy of extracorporeal shock wave lithotripsy (ESWL) for the management of refractory bile duct cholelithiasis in a third level referral centre... - Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothersG Mazzella
Dipartimento di Malattie dell Apparato Digerente, del Metabolismo and delle Malattie Infettive, Azienda Ospedaliera di Bologna, Universita di Bologna, Italy
Hepatology 33:504-8. 2001..8 +/- 2.4 and 0.9 +/- 0.14 micromol/L, respectively. We conclude that increasing the dose of UDCA more effectively controls ICP and improves maternal clinical outcome after delivery... - A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosisF Azzaroli
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
Aliment Pharmacol Ther 24:129-36. 2006..Incidence of hepatocellular carcinoma in hepatitis C virus-related cirrhosis is 4% per year. Although cost-effective, current screening could be improved... - Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosisE Roda
Department of Internal Medicine and Gastroenterology, University of Bologna, S. Drsola-Malpighi Hospital, Italy
Dig Liver Dis 34:523-7. 2002..CONCLUSIONS: In early primary biliary cirrhosis, higher dose ursodeoxycholic acid appears to be more effective than doses currently recommended... - The UDCA dosage deficit: a fate shared with CDCAEnrico Roda
Dipartimento di Medicina Interna e Gastroenterologia, , Bologna, Italy
Eur J Gastroenterol Hepatol 14:213-6. 2002..It may be necessary to re-evaluate the dosage of UDCA that provides the most effective treatment... - Transjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant womanF Lodato
Department of Digestive Diseases and Internal Medicine, S Orsola Malpighi Hospital, University of Bologna, Italy
Dig Liver Dis 40:387-90. 2008..Transjugular intrahepatic portosystemic shunt may represent a rescue treatment for failed attempts of band ligation or sclerotherapy... - Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized studyF Lodato
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
J Viral Hepat 12:536-42. 2005.... - Generation of a novel antibody probe to the apical sodium-dependent bile acid transporter that inhibits ileal bile acid absorptionM Montagnani
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
Mol Pharm 6:1012-8. 2009.... - Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutationsA Floreani
Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
Aliment Pharmacol Ther 23:1649-53. 2006..The aetiology of intrahepatic cholestasis of pregnancy is unknown, but more than 10 different MDR3 gene mutations have recently been identified... - Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patientsA Colecchia
Dipartmento di Medicina Interna e Gastroenterologia Policlinico S.Orsola-Malpighi Via Massarenti 9, Bologna 40138, Italy
World J Gastroenterol 12:5336-43. 2006..These results confirm the pathogenetic role of gastrointestinal motility in gallstone disease and suggest an additional mechanism of action for UDCA in reducing bile cholesterol supersaturation... - Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the ratJ Lee
Liver Center and Department of Medicine, Yale University School of Medicine, 1080 LMP, New Haven, CT 06520-8019, USA
Gastroenterology 121:1473-84. 2001..These responses may facilitate extrahepatic pathways for bile salt excretion during cholestasis... - Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liverC J Soroka
Liver Center and Department of Medicine, Yale University School of Medicine, New Haven, CT 06520-8019, USA
Hepatology 33:783-91. 2001..This was in contrast to the progressive decrease in Mrp2 protein. Because Mrp3 is capable of transporting toxic bile acids, up-regulation of Mrp3 may compensate for the down-regulation of Mrp2 in obstructive cholestasis... - Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancyA Floreani
Department of Surgical and Gastroenterological Sciences, Padua University, Padova, Italy
Dig Liver Dis 40:366-70. 2008..Intrahepatic cholestasis of pregnancy is a multifactorial disorder of pregnancy associated with a genetic background...